Incruse Ellipta and Pms-Sodium Polystyrene Sulfonate
Determining the interaction of Incruse Ellipta and Pms-Sodium Polystyrene Sulfonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Incruse Ellipta-Pneumococcal 13-valent conjugate vaccine
- Incruse Ellipta-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Incruse Ellipta-Pneumococcal Conjugate Vaccine (13-Valent)
- Incruse Ellipta-Pneumococcal Conjugate Vaccine (7-Valent)
- Incruse Ellipta-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Incruse Ellipta-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pms-Sodium Polystyrene Sulfonate-Indacaterol
- Pms-Sodium Polystyrene Sulfonate-Indacaterol and Glycopyrrolate
- Pms-Sodium Polystyrene Sulfonate-Indacaterol and glycopyrrolate Inhalation
- Pms-Sodium Polystyrene Sulfonate-Indacaterol inhalation
- Pms-Sodium Polystyrene Sulfonate-Indacaterol Maleate
- Pms-Sodium Polystyrene Sulfonate-Indapamide